Health Cor Management, L.P. Chinook Therapeutics, Inc. Transaction History

Health Cor Management, L.P.

  • $106 Million
  • Q4 2022

A detailed history of Health Cor Management, L.P. transactions in Chinook Therapeutics, Inc. stock. As of the latest transaction made, Health Cor Management, L.P. holds 60,000 shares of KDNY stock, worth $0. This represents 1.49% of its overall portfolio holdings.

Number of Shares
60,000
Previous 266,830 77.51%
Holding current value
$0
Previous $5.25 Million 70.03%
% of portfolio
1.49%
Previous 0.66%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$18.63 - $27.35 $3.85 Million - $5.66 Million
-206,830 Reduced 77.51%
60,000 $1.57 Million
Q3 2022

Nov 14, 2022
BUY
$17.51 - $23.37 $4.67 Million - $6.24 Million
266,830 New
266,830 $5.25 Million

Others Institutions Holding KDNY

# of Institutions
5
Shares Held
234K
Call Options Held
0
Put Options Held
0
View Full List

About CHINOOK THERAPEUTICS, INC.

KDNY Quotes by TradingView
  • Ticker KDNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,896,300
  • Description
  • Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...
More about KDNY
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email